Deaths reported in Pfizer arthritis trial
April 26, 2011Research and Development, Sales and Marketing Pfizer, rheumatoid arthritis, tofacitinib
Four deaths have been reported in a late-stage study of Pfizer’s arthritis drug tofacitinib. Three of the deaths are thought …
Anglo-Chinese joint venture makes first API batches
April 26, 2011Manufacturing and Production China, Hebei Aoxing Pharmaceutical, Macfarlan Smith, manufacturing and production
China’s Hebei Aoxing Pharmaceutical has passed a major milestone in its joint venture with process technology specialist Macfarlan Smith to …
Sten Westerberg joins BioInvent
April 26, 2011Research and Development appointment, research and development, sales and marketing
Swedish pharma company BioInvent International has appointed Sten Westerberg to the newly-created position of vice president investor relations. Sten is …
Top 5 reasons for a Class I product recall
April 21, 2011Manufacturing and Production Johnson & Johnson, product recalls
Having to recall a pharmaceutical product because of a major quality defect or safety issue is a heart sinking moment …
Digital Pharma: Boehringer UK tweets politicians with afib message
April 21, 2011Medical Communications Boehringer Ingelheim, Digital Pharma blog, Twitter, medical communications
Boehringer Ingelheim UK is using Twitter to reach politicians with local disease awareness messages. About a third of MPs have …
WPP launches UK healthcare digital division
April 21, 2011Medical Communications Ogilvy, Ogilvy Healthworld UK, OgilvyHealthPR, WPP, medical communications, ogilvy healthworld advertising
Communications giant WPP has merged the digital activities of two media brands to launch a new entity in the UK, …
UCB and Amgen’s osteoporosis drug shows promise
April 21, 2011Research and Development Amgen, UCB, osteoporosis
Amgen and UCB have announced strong results from a phase II study of their new postmenopausal osteoporosis treatment. Most existing …
Report sounds off-label prescribing warning
April 21, 2011Sales and Marketing EAASM, off label
A pharma-backed group has warned that some ‘off-label’ prescribing is dangerous for patients. A report by the European Alliance for …
Trevor Smith to lead Takeda in Europe
April 21, 2011Research and Development, Sales and Marketing appointment, research and development, sales and marketing
Trevor Smith has been appointed chief executive of Takeda Pharmaceuticals Europe. Smith brings more than 30 years of pharmaceutical experience …
Saving billions through ‘innovation’ – can the NHS pull it off?
April 21, 2011NHS reforms
Innovation is not a concept immediately associated with the UK’s national health service, but is now being promoted by the …
Procurement pitfalls and hurdles of lab equipment for clinical trials
April 20, 2011Research and Development clinical trials, medical equipment, mesm, procurement
Over $78 billion is spent every year in the clinical trial market in the pursuit of bringing new drugs and …
Eisai launches cancer drug Halaven in UK
April 20, 2011Sales and Marketing Eisai, Halaven, breast cancer
Eisai’s sea sponge derived breast cancer drug Halaven has been launched in the UK following approval from European regulators a …
Novavax appoints Stanley Erck chief executive
April 20, 2011Research and Development appointment, research and development
US biopharmaceutical company Novavax has reorganised its senior management. The changes see former executive chairman Stanley Erck take on the …
Generics push US drug growth to $307bn
April 20, 2011IMS, IMS Health, drug spending, healthcare spending
Generics replaced branded drugs as the main growth drivers for the US pharmaceutical market in 2010. The market saw just …
Warner Chilcott plans to axe 500 jobs in Europe
April 20, 2011Manufacturing and Production, Research and Development, Sales and Marketing Warner Chilcott, pharma job cuts
Warner Chilcott is looking to cut 500 jobs from its European operations as it seeks to minimise the impact of …
Contract research news in brief
April 20, 2011Research and Development CRO, contract research
Our contract research news round-up features updates from BioClinica, Vyteris, CROMSOURCE, Quintiles, Imperial/D. Anderson and PRA International. Clinical trial management …
Life Healthcare Communications expands
April 20, 2011Medical Communications appointment, medical communications
Life Healthcare Communications has expanded, adding new employees and extending its existing digital department.The Berkshire, UK-based creative communications agency has …
Circassia raises funds to develop allergy products
April 19, 2011Research and Development Circassia, UK biotech, biotech
UK biopharma company Circassia has raised £60 million funding for the final stage of development of its anti-allergy products. The …
Oral MS drug Gilenya launched in the UK
April 19, 2011Sales and Marketing Novartis, gilenya, multiple sclerosis
Gilenya has become the first oral multiple sclerosis drug to be launched in the UK. Gilenya (fingolimod) is licenced to …
NICE unimpressed with Novartis’ patient access scheme
April 19, 2011Sales and Marketing Afinitor, Kidney cancer, NICE, Novartis
Novartis has been dealt a blow by NICE after the cost-effectiveness body finally refused to recommend, on appeal, its kidney …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
